BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8640446)

  • 21. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
    Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
    J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of tyrosine kinase and protein kinase C in the induction of nitric oxide synthase by lipopolysaccharide and interferon-gamma in J774 macrophages.
    Eason S; Martin W
    Arch Int Pharmacodyn Ther; 1995; 330(2):225-40. PubMed ID: 8861714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression.
    Aguayo J; Iitaka M; Row VV; Volpé R
    J Clin Endocrinol Metab; 1988 May; 66(5):903-8. PubMed ID: 3129449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
    Carrel S; Schmidt-Kessen A; Giuffrè L
    Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of intracellular calcium concentration and protein kinase C activation in IFN-gamma stimulation of U937 cells.
    Klein JB; Schepers TM; Dean WL; Sonnenfeld G; McLeish KR
    J Immunol; 1990 Jun; 144(11):4305-11. PubMed ID: 2140394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different roles of PKC and PKA in effect of interferon-gamma on proliferation and collagen synthesis of fibroblasts.
    Zhang XF; Guo SZ; Lu KH; Li HY; Li XD; Zhang LX; Yang L
    Acta Pharmacol Sin; 2004 Oct; 25(10):1320-6. PubMed ID: 15456534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of HLA-DR and invariant chain expression by human peripheral blood mononuclear cells with lead, interferon-gamma, or interleukin-4.
    Guo TL; Mudzinski SP; Lawrence DA
    Cell Immunol; 1996 Jul; 171(1):1-9. PubMed ID: 8660831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts.
    Geppert TD; Lipsky PE
    J Immunol; 1987 Jan; 138(2):385-92. PubMed ID: 3098840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic evidence for the requirement of protein kinase C in IFN-induced macrophage Fc gamma receptor and Ia antigen expression.
    Politis AD; Vogel SN
    J Immunol; 1990 Dec; 145(11):3788-95. PubMed ID: 1700995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative regulation of MHC class II gene expression by CXCR4.
    Sheridan C; Sadaria M; Bhat-Nakshatri P; Goulet R; Edenberg HJ; McCarthy BP; Chang CH; Srour EF; Nakshatri H
    Exp Hematol; 2006 Aug; 34(8):1085-92. PubMed ID: 16863915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells.
    De Saint Jean M; Brignole F; Feldmann G; Goguel A; Baudouin C
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2199-212. PubMed ID: 10476784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of interferon-gamma on the response of human thyrocytes to thyrotropin (TSH) stimulation: relationship between the response to TSH and the expression of DR antigen.
    Nagayama Y; Izumi M; Ashizawa K; Kiriyama T; Yokoyama N; Morita S; Ohtakara S; Fukuda T; Eguchi K; Morimoto I
    J Clin Endocrinol Metab; 1987 May; 64(5):949-53. PubMed ID: 3031123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells.
    Mori K; Stone S; Braverman LE; DeVito WJ
    Endocrinology; 1996 Nov; 137(11):4994-9. PubMed ID: 8895373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
    Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
    Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase C regulates MHC-class II expression on endothelial cells.
    Mattila P; Renkonen R
    Scand J Immunol; 1991 Aug; 34(2):153-60. PubMed ID: 1907763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
    Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
    Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
    Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
    J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.